Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA
Overview
Authors
Affiliations
Background: Inflammatory bowel disease (IBD) is a chronic, debilitating condition with high emergency department (ED) utilization. We aimed to investigate the utilization patterns of ED by IBD patients and measure hospitalization and surgical rates following ED visits.
Methods: We conducted a cross-sectional study of adults with IBD listed as the primary ED diagnosis from the 2009 to 2011 Nationwide Emergency Department Sample. The characteristics of the IBD-related ED visits in relation to following hospitalizations and surgeries were analyzed.
Results: Adult IBD patients constitute 0.09 % of the total ED visits. Crohn's disease (CD) contributed to 69 % of the IBD-ED visits. The hospitalization rate from ED was 59.9 % nationally, ranging from 56 % in west to 69 % in northeast. The most significant factors associated with hospitalization were intra-abdominal abscess [odds ratio (OR) 24.22], bowel obstruction (OR 17.77), anemia (OR 7.54), malnutrition (OR 6.29), hypovolemia/electrolyte abnormalities (OR 5.57), and fever/abnormal white cell count (OR 3.18). Patients with CD (OR 0.66), low-income group (OR 0.90), and female gender (OR 0.87) have a lower odds of getting hospitalized. Age above 65 years (OR 1.63), CD (OR 1.89), bowel obstruction (OR 9.24), and intra-abdominal abscess (OR 18.41) were significantly associated with surgical intervention.
Conclusion: The IBD-related ED visits have remained relatively stable from 2009 to 2011. The presence of anemia, malnutrition, hypovolemia, electrolyte abnormalities, fever, abnormal white cell count, bowel obstruction, or intra-abdominal abscess during the ED visit was associated with hospitalization. The presence of bowel obstruction and intra-abdominal abscess was strongly associated with surgical intervention.
Istratescu D, Preda C, Manuc T, Meianu C, Stroie T, Diculescu M Medicina (Kaunas). 2024; 60(7).
PMID: 39064497 PMC: 11278540. DOI: 10.3390/medicina60071068.
Rasmussen N, Moos C, Gregersen L, Hikmat Z, Andersen V, Green A Syst Rev. 2024; 13(1):164.
PMID: 38915086 PMC: 11194997. DOI: 10.1186/s13643-024-02584-3.
Cadoni M, Favale A, Piras R, Demurtas M, Soddu P, Usai A Nutrients. 2024; 16(11).
PMID: 38892491 PMC: 11173774. DOI: 10.3390/nu16111557.
Dziegielewski C, Gupta S, Begum J, Pugliese M, Lombardi J, E K BMC Gastroenterol. 2024; 24(1):172.
PMID: 38760679 PMC: 11102236. DOI: 10.1186/s12876-024-03226-7.
Lytvyak E, Sutton R, Dieleman L, Peerani F, Fedorak R, Kroeker K Crohns Colitis 360. 2023; 2(4):otaa080.
PMID: 36777757 PMC: 9802474. DOI: 10.1093/crocol/otaa080.